Mason, J.W., Oconnel, J.B., Herskowitz, A., et al. (1995) Myocarditis Treatment Trial Investigators. A Clinical Trial of Immunosuppressive Therapy for Myocarditis. The New England Journal of Medicine, 333, 262-275.
https://doi.org/10.1056/NEJM199508033330501

has been cited by the following article:

• TITLE: Myocarditis after COVID-19 Vaccination

  AUTHORS: Naoki Hashimoto, Kazuhiro Kashio

  KEYWORDS: COVID-19, mRNA-Based Vaccine, Myocarditis, Spike Protein

  JOURNAL NAME: Open Journal of Emergency Medicine, Vol.11 No.1, March 31, 2023

  ABSTRACT: Aim: The ongoing COVID-19 pandemic is an acute medical, social, political and economic problem. Acute myocarditis is a rare complication of the widely used mRNA-based vaccines. Case Presentation: 20-year old male with no preexisting disease or cardiovascular risk factor presented in October 2021 with chest pain after receiving the second dose of the Moderna COVID-19 vaccine 2 days previously. He discharged from ward care only a few days after his initial presentation. Conclusion: Despite the meta-analysis results suggesting a higher risk of myocarditis with COVID-19 vaccination, vaccination should still be recommended because benefits of the vaccine likely outweigh its harms.